Personal information

Medicinal Chemistry, Drug Design, Targeted Therapy
China

Activities

Education and qualifications (2)

Sichuan University: Chengdu, Sichuan, CN

2020-09-01 to 2028-06-01 (State Key Labortory of Oral Disease, School of stomatology)
Education
Source: Self-asserted source
Yilin Gu

West China Hospital of Sichuan University: Chengdu, Sichuan, CN

2021-12-01 to 2024-06-01 (Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Joint Research Institution of Altitude Health, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu)
Education
Source: Self-asserted source
Yilin Gu

Works (4)

Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial

The Lancet
2024-07 | Journal article
Part of ISSN: 0140-6736
Contributors: Yilin Gu
Source: Self-asserted source
Yilin Gu

Bispecific antibody drug conjugates: Making 1+1>2

Acta Pharmaceutica Sinica B
2024-05 | Journal article
Contributors: Yilin Gu; Zhijia Wang; Yuxi Wang
Source: check_circle
Crossref

Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways

European Journal of Medicinal Chemistry
2023-08 | Journal article
Part of ISSN: 0223-5234
Contributors: Wenxin Luo; Yilin Gu; Siyu Fu; Jiaxing Wang; Jifa Zhang; Yuxi Wang
Source: Self-asserted source
Yilin Gu
grade
Preferred source (of 2)‎

Targeting ferroptosis: Paving new roads for drug design and discovery

European Journal of Medicinal Chemistry
2023-02 | Journal article
Part of ISSN: 0223-5234
Contributors: Yilin Gu; Yizhe Li; Jiaxing Wang; Lele Zhang; Jifa Zhang; Yuxi Wang
Source: Self-asserted source
Yilin Gu
grade
Preferred source (of 2)‎